533 related articles for article (PubMed ID: 35879449)
21. Targeting tumor associated macrophages in hepatocellular carcinoma.
Xu W; Cheng Y; Guo Y; Yao W; Qian H
Biochem Pharmacol; 2022 May; 199():114990. PubMed ID: 35288152
[TBL] [Abstract][Full Text] [Related]
22. Colorectal cancer-derived extracellular vesicles containing HSP70 enhance macrophage phagocytosis by up-regulating MARCO expression.
Sun Y; Xiao W; Yu Y; Jiang Y; Xiao Z; Huang D; Zhong T; Li J; Xiang X; He Y; Li Z
Exp Cell Res; 2023 May; 426(2):113565. PubMed ID: 36958650
[TBL] [Abstract][Full Text] [Related]
23. VentX expression in tumor-associated macrophages promotes phagocytosis and immunity against pancreatic cancers.
Le Y; Gao H; Richards W; Zhao L; Bleday R; Clancy T; Zhu Z
JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32573491
[TBL] [Abstract][Full Text] [Related]
24. The roles of tumor-associated macrophages in tumor angiogenesis and metastasis.
Fu LQ; Du WL; Cai MH; Yao JY; Zhao YY; Mou XZ
Cell Immunol; 2020 Jul; 353():104119. PubMed ID: 32446032
[TBL] [Abstract][Full Text] [Related]
25. Similarities between wound re-epithelialization and Metastasis in ESCC and the crucial involvement of macrophages: A review.
Chabeli MS; Wang X; Yinghao L; Chen C; Yang C; Shou Y; Wang S; Chen K
Cancer Treat Res Commun; 2022; 32():100621. PubMed ID: 36007473
[TBL] [Abstract][Full Text] [Related]
26. Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow-Derived Macrophages.
Wu M; Wu L; Wu W; Zhu M; Li J; Wang Z; Li J; Ding R; Liang Y; Li L; Zhang T; Huang B; Cai Y; Li K; Li L; Zhang R; Hu B; Lin F; Wang X; Zheng S; Chen J; You Y; Jiang T; Zhang J; Chen H; Wang Q
Cancer Res; 2023 Mar; 83(5):771-785. PubMed ID: 36622331
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance and targeting tumor-associated macrophages in cancer: new insights and future perspectives.
Mehraj U; Qayoom H; Mir MA
Breast Cancer; 2021 May; 28(3):539-555. PubMed ID: 33661479
[TBL] [Abstract][Full Text] [Related]
28. The Role of Tumor Associated Macrophages (TAMs) in Cancer Progression, Chemoresistance, Angiogenesis and Metastasis - Current Status.
Dallavalasa S; Beeraka NM; Basavaraju CG; Tulimilli SV; Sadhu SP; Rajesh K; Aliev G; Madhunapantula SV
Curr Med Chem; 2021; 28(39):8203-8236. PubMed ID: 34303328
[TBL] [Abstract][Full Text] [Related]
29. Functional polarization of tumor-associated macrophages dictated by metabolic reprogramming.
Zeng W; Li F; Jin S; Ho PC; Liu PS; Xie X
J Exp Clin Cancer Res; 2023 Sep; 42(1):245. PubMed ID: 37740232
[TBL] [Abstract][Full Text] [Related]
30. Metabolic reprogramming in the immunosuppression of tumor-associated macrophages.
Wang Y; Wang D; Yang L; Zhang Y
Chin Med J (Engl); 2022 Oct; 135(20):2405-2416. PubMed ID: 36385099
[TBL] [Abstract][Full Text] [Related]
31. Significance of the Tumor Microenvironment in Liver Cancer Progression.
Muppala S
Crit Rev Oncog; 2020; 25(1):1-9. PubMed ID: 32865906
[TBL] [Abstract][Full Text] [Related]
32. The Roles and Targeting of Tumor-Associated Macrophages.
Li Y; Wang R; Gao Q
Front Biosci (Landmark Ed); 2023 Sep; 28(9):207. PubMed ID: 37796698
[TBL] [Abstract][Full Text] [Related]
33. Tumor-associated macrophage-derived chemokine CCL5 facilitates the progression and immunosuppressive tumor microenvironment of clear cell renal cell carcinoma.
Xu W; Wu Y; Liu W; Anwaier A; Tian X; Su J; Huang H; Wei G; Qu Y; Zhang H; Ye D
Int J Biol Sci; 2022; 18(13):4884-4900. PubMed ID: 35982911
[No Abstract] [Full Text] [Related]
34. Tumor microenvironment remodeling via targeted depletion of M2-like tumor-associated macrophages for cancer immunotherapy.
Cao Y; Qiao B; Chen Q; Xie Z; Dou X; Xu L; Ran H; Zhang L; Wang Z
Acta Biomater; 2023 Apr; 160():239-251. PubMed ID: 36774974
[TBL] [Abstract][Full Text] [Related]
35. Manipulation of the tumor immuno-microenvironment via TAM-targeted expression of transcription factors.
Musick M; Yu X
Immunol Res; 2022 Aug; 70(4):432-440. PubMed ID: 35486115
[TBL] [Abstract][Full Text] [Related]
36. Targeting tumor-associated macrophages in the tumor microenvironment.
Zhou K; Cheng T; Zhan J; Peng X; Zhang Y; Wen J; Chen X; Ying M
Oncol Lett; 2020 Nov; 20(5):234. PubMed ID: 32968456
[TBL] [Abstract][Full Text] [Related]
37. Targeting tumor-associated macrophages for cancer immunotherapy.
Cao X; Lai SWT; Chen S; Wang S; Feng M
Int Rev Cell Mol Biol; 2022; 368():61-108. PubMed ID: 35636930
[TBL] [Abstract][Full Text] [Related]
38. Single-cell atlas of the immune microenvironment reveals macrophage reprogramming and the potential dual macrophage-targeted strategy in multiple myeloma.
Li J; Yang Y; Wang W; Xu J; Sun Y; Jiang J; Tan H; Ren L; Wang Y; Ren Y; Zhang Y; Xu T; Jia X; Huang X; Liu P
Br J Haematol; 2023 Jun; 201(5):917-934. PubMed ID: 36852636
[TBL] [Abstract][Full Text] [Related]
39. In Vivo Analysis of Tumor-Associated Macrophages in the Tumor Microenvironment.
Anfray C; Ummarino A; Calvo A; Allavena P; Torres Andón F
Methods Mol Biol; 2023; 2614():93-108. PubMed ID: 36587121
[TBL] [Abstract][Full Text] [Related]
40. Tumor promoting role of anti-tumor macrophages in tumor microenvironment.
Goswami KK; Ghosh T; Ghosh S; Sarkar M; Bose A; Baral R
Cell Immunol; 2017 Jun; 316():1-10. PubMed ID: 28433198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
